Efficacy Results of Pimavanserin from a Multi-Center, Open-Label Extension Study in Parkinson's Disease Psychosis Patients
                        AuthID
P-00T-XB0
                
    P-00T-XB0
© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service